Consequently, in breast cancer, the transition from a less aggressive to a metastatic phenotype is characterized by PRKD1 (PKD1) gene promoter methylation and downregulation of PKD1 expression [14, 26]. This evidence concerns the gene PRKD1 and breast cancer.